FIRST AMENDMENT TO AMENDED AND RESTATED LEASELease • July 5th, 2017 • Halozyme Therapeutics Inc • Biological products, (no disgnostic substances)
THIS FIRST AMENDMENT TO AMENDED AND RESTATED LEASE (this “Amendment”) is entered into as of this 30th day of June, 2017 (the “First Amendment Execution Date”), by and between BMR-11388 SORRENTO VALLEY ROAD LP, a Delaware limited partnership (“Landlord,” formerly known as BMR-11388 Sorrento Valley Road LLC), and HALOZYME, INC., a California corporation (“Tenant”).
SECOND MODIFICATION TO LEASE DATED OCTOBER 24, 2012 BY AND BETWEEN CAL- SORRENTO, LTD., A CALIFORNIA LIMITED PARTNERSHIP AS LESSOR AND HALOZYME THERAPEUTICS, INC., A DELAWARE CORPORATION AND HALOZYME, INC., A CALIFORNIA CORPORATION AS LESSEEHalozyme Therapeutics Inc • July 5th, 2017 • Biological products, (no disgnostic substances)
